These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28405501)

  • 61. Increased expression of PD‑L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity.
    Liu C; Lu J; Tian H; Du W; Zhao L; Feng J; Yuan D; Li Z
    Mol Med Rep; 2017 Mar; 15(3):1063-1070. PubMed ID: 28075442
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling.
    Lucas J; Hsieh TC; Halicka HD; Darzynkiewicz Z; Wu JM
    Int J Oncol; 2018 Oct; 53(4):1469-1480. PubMed ID: 30066852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Scavenger Receptor Class B Type 1 (SR-B1) being a Potential Biomarker for the Diagnosis of Liposarcoma and Associated with the Degree of Differentiation of Liposarcomas.
    Liu Q; Li Z; Shang H; Zhang Q; Wang X; Zhang Y; Wang Y; Li Q; Li C; Liu C; Li F
    J Cancer; 2019; 10(18):4326-4332. PubMed ID: 31413752
    [No Abstract]   [Full Text] [Related]  

  • 64. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
    Takahiro T; Shinichi K; Toshimitsu S
    Clin Cancer Res; 2003 Jun; 9(6):2204-12. PubMed ID: 12796387
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Global and Integrated Analysis of CINSARC-Associated Genetic Defects.
    Lesluyes T; Chibon F
    Cancer Res; 2020 Dec; 80(23):5282-5290. PubMed ID: 33023949
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma.
    Benassi MS; Pazzaglia L; Novello C; Quattrini I; Pollino S; Magagnoli G; Picci P; Conti A
    Am J Cancer Res; 2015; 5(11):3446-54. PubMed ID: 26807324
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Very long-term survivors among patients with metastatic soft tissue sarcoma.
    Carbonnaux M; Brahmi M; Schiffler C; Meeus P; Sunyach MP; Bouhamama A; Karanian M; Tirode F; Pissaloux D; Vaz G; Ray-Coquard I; Blay JY; Dufresne A
    Cancer Med; 2019 Apr; 8(4):1368-1378. PubMed ID: 30916474
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
    Croce S; Lesluyes T; Valle C; M'Hamdi L; Thébault N; Pérot G; Stoeckle E; Noël JC; Fontanges Q; Devouassoux-Shisheboran M; Querleu D; Guyon F; Floquet A; Chakiba C; Mayeur L; Rebier F; MacGrogan GM; Soubeyran I; Le Guellec S; Chibon F
    Clin Cancer Res; 2020 Feb; 26(4):855-861. PubMed ID: 31796515
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy.
    Vincenzi B; Santini D; Schiavon G; Frezza AM; Silletta M; Crucitti P; Casali P; Dei Tos AP; Rossi S; Rizzo S; Badalamenti G; Tomasino RM; Russo A; Butrynski JE; Tonini G
    J Cell Physiol; 2012 Apr; 227(4):1657-62. PubMed ID: 21678421
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.
    Pollino S; Benassi MS; Pazzaglia L; Conti A; Bertani N; Righi A; Piccinni-Leopardi M; Picci P; Perris R
    Histol Histopathol; 2018 Jun; 33(6):597-608. PubMed ID: 29297565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PDL1 expression in desmoplastic melanoma is associated with tumor aggressiveness and progression.
    Kraft S; Fernandez-Figueras MT; Richarz NA; Flaherty KT; Hoang MP
    J Am Acad Dermatol; 2017 Sep; 77(3):534-542. PubMed ID: 28728868
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation.
    Dieterich LC; Ikenberg K; Cetintas T; Kapaklikaya K; Hutmacher C; Detmar M
    Front Immunol; 2017; 8():66. PubMed ID: 28217128
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer.
    Manjarrez-Orduño N; Menard LC; Kansal S; Fischer P; Kakrecha B; Jiang C; Cunningham M; Greenawalt D; Patel V; Yang M; Golhar R; Carman JA; Lezhnin S; Dai H; Kayne PS; Suchard SJ; Bernstein SH; Nadler SG
    Front Immunol; 2018; 9():1613. PubMed ID: 30123214
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer.
    Polónia A; Pinto R; Cameselle-Teijeiro JF; Schmitt FC; Paredes J
    J Clin Pathol; 2017 Oct; 70(10):860-867. PubMed ID: 28373294
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    Birnbaum DJ; Finetti P; Birnbaum D; Mamessier E; Bertucci F
    J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31052304
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Minimal Increase in Survival Throughout the Years in Patients with Soft Tissue Sarcoma with Synchronous Metastases: Results of a Population-Based Study.
    Vos M; Ho VKY; Oosten AW; Verhoef C; Sleijfer S
    Oncologist; 2019 Jul; 24(7):e526-e535. PubMed ID: 30190301
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database.
    Salas S; Bui B; Stoeckle E; Terrier P; Ranchere-Vince D; Collin F; Leroux A; Guillou L; Michels JJ; Trassard M; Valo I; Robin YM; Marques B; Brouste V; Coindre JM
    Ann Oncol; 2009 Jun; 20(6):1127-35. PubMed ID: 19179555
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Matrix metalloproteinase expression in high grade soft tissue sarcomas.
    Alford SH; Vrana MS; Waite L; Heim-Hall J; Sylvia VL; Williams RP
    Oncol Rep; 2007 Dec; 18(6):1529-36. PubMed ID: 17982640
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The B7H4-PDL1 classifier stratifies immuno-phenotype in cervical cancer.
    Chen L; Dong J; Li Z; Chen Y; Zhang Y
    Cancer Cell Int; 2022 Jan; 22(1):3. PubMed ID: 34983532
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas.
    Stinson JA; Sheen A; Momin N; Hampel J; Bernstein R; Kamerer R; Fadl-Alla B; Samuelson J; Fink E; Fan TM; Wittrup KD
    Clin Cancer Res; 2023 Jun; 29(11):2110-2122. PubMed ID: 37014656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.